BMO Capital analyst Sean Dodge initiated coverage of Teladoc (TDOC) with a Market Perform rating and $8 price target Teladoc remains the leading telehealth and virtual mental health provider, though growth has slowed since the pandemic, the analyst tells investors in a research note. Management’s efforts to revive revenue show early promise, and greater adoption of BetterHelp through insurance, stabilization of U.S. cash-pay users, and sustained international momentum could strengthen the outlook, the firm says.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc’s Growth and Execution Challenges: A ‘Show-Me’ Story with Potential Market Opportunities
- Teladoc’s Stock Dips Amid Analyst Caution
- Teladoc Health’s Earnings Call: Resilience Amid Challenges
- Teladoc’s Strategic Acquisitions Show Promise Amid Competitive Challenges: Hold Rating Justified
- Teladoc’s Strategic Investments and Growth Uncertainty Lead to Hold Rating Amid CFO Transition